Outcomes of Home Oxygen Use in Extremely Preterm Infants with Bronchopulmonary Dysplasia

Home oxygen was associated with only minimal growth superiority and no neurodevelopmental advantage at 18 to 26 weeks' corrected age.

Bronchopulmonary dysplasia (BPD) is common in extremely preterm infants, some of whom are prescribed supplemental home oxygen to improve neurodevelopmental outcomes. Yet the effectiveness of this therapy remains unknown.

Using data from a neonatal network registry, investigators conducted a propensity score–matched cohort study in infants born at <27 weeks' gestation and receiving supplemental oxygen or respiratory support at 36 weeks' postmenstrual age. Primary outcomes were rehospitalization and weight z-score, and secondary outcomes included growth, neurodevelopmental, behavioral, and medical resource use indicators. Assessments occurred at 18 to 26 weeks' corrected age in 1039 infants discharged on supplemental home oxygen and 1039 disch…

Reviewing Author

F. Bruder Stapleton, MD

Disclosures

Consultant/Advisory BoardCareer Physician

Editorial BoardsUpToDate

Leadership Positions in Professional SocietiesAmerican Society of Pediatric Nephrology Foundation (Chair)

F. Bruder Stapleton, MD

Disclosures

Consultant/Advisory BoardCareer Physician

Editorial BoardsUpToDate

Leadership Positions in Professional SocietiesAmerican Society of Pediatric Nephrology Foundation (Chair)

Outcomes of Home Oxygen Use in Extremely Preterm Infants with Bronchopulmonary Dysplasia

Topics

Reviewing Author